Global Cardiovascular Drug-Eluting Stents(DES) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Cardiovascular Drug-Eluting Stents(DES) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report is a detailed and comprehensive analysis for global Cardiovascular Drug-Eluting Stents(DES) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiovascular Drug-Eluting Stents(DES) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiovascular Drug-Eluting Stents(DES)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiovascular Drug-Eluting Stents(DES) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical and Reva Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cardiovascular Drug-Eluting Stents(DES) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Cardiovascular Drug-Eluting Stents(DES) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiovascular Drug-Eluting Stents(DES), with price, sales, revenue and global market share of Cardiovascular Drug-Eluting Stents(DES) from 2018 to 2023.
Chapter 3, the Cardiovascular Drug-Eluting Stents(DES) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiovascular Drug-Eluting Stents(DES) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cardiovascular Drug-Eluting Stents(DES) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular Drug-Eluting Stents(DES).
Chapter 14 and 15, to describe Cardiovascular Drug-Eluting Stents(DES) sales channel, distributors, customers, research findings and conclusion.
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report is a detailed and comprehensive analysis for global Cardiovascular Drug-Eluting Stents(DES) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiovascular Drug-Eluting Stents(DES) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiovascular Drug-Eluting Stents(DES) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiovascular Drug-Eluting Stents(DES)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiovascular Drug-Eluting Stents(DES) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical and Reva Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cardiovascular Drug-Eluting Stents(DES) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Passive Coating
- Active Coating
- Hospital
- Clinic
- MIV Therapeutics
- Orbusneich
- Promed Medical
- Relisys Medical
- Reva Medical
- Sahajanand
- Sino Medical
- Sorin
- Terumo Medical
- Abbott Vascular
- Advantec Vascular
- B.Braun Melsengen AG
- Biosensors
- Boston Scientific
- MicroPort Medical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Cardiovascular Drug-Eluting Stents(DES) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiovascular Drug-Eluting Stents(DES), with price, sales, revenue and global market share of Cardiovascular Drug-Eluting Stents(DES) from 2018 to 2023.
Chapter 3, the Cardiovascular Drug-Eluting Stents(DES) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiovascular Drug-Eluting Stents(DES) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cardiovascular Drug-Eluting Stents(DES) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular Drug-Eluting Stents(DES).
Chapter 14 and 15, to describe Cardiovascular Drug-Eluting Stents(DES) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cardiovascular Drug-Eluting Stents(DES)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Passive Coating
1.3.3 Active Coating
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Cardiovascular Drug-Eluting Stents(DES) Market Size & Forecast
1.5.1 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (2018-2029)
1.5.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 MIV Therapeutics
2.1.1 MIV Therapeutics Details
2.1.2 MIV Therapeutics Major Business
2.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.1.4 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 MIV Therapeutics Recent Developments/Updates
2.2 Orbusneich
2.2.1 Orbusneich Details
2.2.2 Orbusneich Major Business
2.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.2.4 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Orbusneich Recent Developments/Updates
2.3 Promed Medical
2.3.1 Promed Medical Details
2.3.2 Promed Medical Major Business
2.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.3.4 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Promed Medical Recent Developments/Updates
2.4 Relisys Medical
2.4.1 Relisys Medical Details
2.4.2 Relisys Medical Major Business
2.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.4.4 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Relisys Medical Recent Developments/Updates
2.5 Reva Medical
2.5.1 Reva Medical Details
2.5.2 Reva Medical Major Business
2.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.5.4 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Reva Medical Recent Developments/Updates
2.6 Sahajanand
2.6.1 Sahajanand Details
2.6.2 Sahajanand Major Business
2.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.6.4 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sahajanand Recent Developments/Updates
2.7 Sino Medical
2.7.1 Sino Medical Details
2.7.2 Sino Medical Major Business
2.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.7.4 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sino Medical Recent Developments/Updates
2.8 Sorin
2.8.1 Sorin Details
2.8.2 Sorin Major Business
2.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.8.4 Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sorin Recent Developments/Updates
2.9 Terumo Medical
2.9.1 Terumo Medical Details
2.9.2 Terumo Medical Major Business
2.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.9.4 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Terumo Medical Recent Developments/Updates
2.10 Abbott Vascular
2.10.1 Abbott Vascular Details
2.10.2 Abbott Vascular Major Business
2.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.10.4 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Vascular Recent Developments/Updates
2.11 Advantec Vascular
2.11.1 Advantec Vascular Details
2.11.2 Advantec Vascular Major Business
2.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.11.4 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Advantec Vascular Recent Developments/Updates
2.12 B.Braun Melsengen AG
2.12.1 B.Braun Melsengen AG Details
2.12.2 B.Braun Melsengen AG Major Business
2.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.12.4 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 B.Braun Melsengen AG Recent Developments/Updates
2.13 Biosensors
2.13.1 Biosensors Details
2.13.2 Biosensors Major Business
2.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.13.4 Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biosensors Recent Developments/Updates
2.14 Boston Scientific
2.14.1 Boston Scientific Details
2.14.2 Boston Scientific Major Business
2.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.14.4 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boston Scientific Recent Developments/Updates
2.15 MicroPort Medical
2.15.1 MicroPort Medical Details
2.15.2 MicroPort Medical Major Business
2.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.15.4 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 MicroPort Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARDIOVASCULAR DRUG-ELUTING STENTS(DES) BY MANUFACTURER
3.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Manufacturer (2018-2023)
3.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cardiovascular Drug-Eluting Stents(DES) Manufacturer Market Share in 2022
3.4.2 Top 6 Cardiovascular Drug-Eluting Stents(DES) Manufacturer Market Share in 2022
3.5 Cardiovascular Drug-Eluting Stents(DES) Market: Overall Company Footprint Analysis
3.5.1 Cardiovascular Drug-Eluting Stents(DES) Market: Region Footprint
3.5.2 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
3.5.3 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cardiovascular Drug-Eluting Stents(DES) Market Size by Region
4.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2029)
4.1.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2029)
4.1.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2029)
4.2 North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.3 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.4 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.5 South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.6 Middle East and Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
5.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2018-2029)
5.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
6.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2018-2029)
6.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
7.2 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
7.3 North America Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
7.3.1 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
7.3.2 North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
8.2 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
8.3 Europe Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
8.3.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
8.3.2 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Market Size by Region
9.3.1 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
10.2 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
10.3 South America Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
10.3.1 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
10.3.2 South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
11.3.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Cardiovascular Drug-Eluting Stents(DES) Market Drivers
12.2 Cardiovascular Drug-Eluting Stents(DES) Market Restraints
12.3 Cardiovascular Drug-Eluting Stents(DES) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cardiovascular Drug-Eluting Stents(DES) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiovascular Drug-Eluting Stents(DES)
13.3 Cardiovascular Drug-Eluting Stents(DES) Production Process
13.4 Cardiovascular Drug-Eluting Stents(DES) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
14.3 Cardiovascular Drug-Eluting Stents(DES) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Cardiovascular Drug-Eluting Stents(DES)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Passive Coating
1.3.3 Active Coating
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Cardiovascular Drug-Eluting Stents(DES) Market Size & Forecast
1.5.1 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (2018-2029)
1.5.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 MIV Therapeutics
2.1.1 MIV Therapeutics Details
2.1.2 MIV Therapeutics Major Business
2.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.1.4 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 MIV Therapeutics Recent Developments/Updates
2.2 Orbusneich
2.2.1 Orbusneich Details
2.2.2 Orbusneich Major Business
2.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.2.4 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Orbusneich Recent Developments/Updates
2.3 Promed Medical
2.3.1 Promed Medical Details
2.3.2 Promed Medical Major Business
2.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.3.4 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Promed Medical Recent Developments/Updates
2.4 Relisys Medical
2.4.1 Relisys Medical Details
2.4.2 Relisys Medical Major Business
2.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.4.4 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Relisys Medical Recent Developments/Updates
2.5 Reva Medical
2.5.1 Reva Medical Details
2.5.2 Reva Medical Major Business
2.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.5.4 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Reva Medical Recent Developments/Updates
2.6 Sahajanand
2.6.1 Sahajanand Details
2.6.2 Sahajanand Major Business
2.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.6.4 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sahajanand Recent Developments/Updates
2.7 Sino Medical
2.7.1 Sino Medical Details
2.7.2 Sino Medical Major Business
2.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.7.4 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sino Medical Recent Developments/Updates
2.8 Sorin
2.8.1 Sorin Details
2.8.2 Sorin Major Business
2.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.8.4 Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sorin Recent Developments/Updates
2.9 Terumo Medical
2.9.1 Terumo Medical Details
2.9.2 Terumo Medical Major Business
2.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.9.4 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Terumo Medical Recent Developments/Updates
2.10 Abbott Vascular
2.10.1 Abbott Vascular Details
2.10.2 Abbott Vascular Major Business
2.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.10.4 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Vascular Recent Developments/Updates
2.11 Advantec Vascular
2.11.1 Advantec Vascular Details
2.11.2 Advantec Vascular Major Business
2.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.11.4 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Advantec Vascular Recent Developments/Updates
2.12 B.Braun Melsengen AG
2.12.1 B.Braun Melsengen AG Details
2.12.2 B.Braun Melsengen AG Major Business
2.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.12.4 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 B.Braun Melsengen AG Recent Developments/Updates
2.13 Biosensors
2.13.1 Biosensors Details
2.13.2 Biosensors Major Business
2.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.13.4 Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biosensors Recent Developments/Updates
2.14 Boston Scientific
2.14.1 Boston Scientific Details
2.14.2 Boston Scientific Major Business
2.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.14.4 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boston Scientific Recent Developments/Updates
2.15 MicroPort Medical
2.15.1 MicroPort Medical Details
2.15.2 MicroPort Medical Major Business
2.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
2.15.4 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 MicroPort Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARDIOVASCULAR DRUG-ELUTING STENTS(DES) BY MANUFACTURER
3.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Manufacturer (2018-2023)
3.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cardiovascular Drug-Eluting Stents(DES) Manufacturer Market Share in 2022
3.4.2 Top 6 Cardiovascular Drug-Eluting Stents(DES) Manufacturer Market Share in 2022
3.5 Cardiovascular Drug-Eluting Stents(DES) Market: Overall Company Footprint Analysis
3.5.1 Cardiovascular Drug-Eluting Stents(DES) Market: Region Footprint
3.5.2 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
3.5.3 Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cardiovascular Drug-Eluting Stents(DES) Market Size by Region
4.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2029)
4.1.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2029)
4.1.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2029)
4.2 North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.3 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.4 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.5 South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
4.6 Middle East and Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
5.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2018-2029)
5.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
6.2 Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2018-2029)
6.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
7.2 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
7.3 North America Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
7.3.1 North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
7.3.2 North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
8.2 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
8.3 Europe Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
8.3.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
8.3.2 Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Market Size by Region
9.3.1 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
10.2 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
10.3 South America Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
10.3.1 South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
10.3.2 South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Market Size by Country
11.3.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Cardiovascular Drug-Eluting Stents(DES) Market Drivers
12.2 Cardiovascular Drug-Eluting Stents(DES) Market Restraints
12.3 Cardiovascular Drug-Eluting Stents(DES) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cardiovascular Drug-Eluting Stents(DES) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiovascular Drug-Eluting Stents(DES)
13.3 Cardiovascular Drug-Eluting Stents(DES) Production Process
13.4 Cardiovascular Drug-Eluting Stents(DES) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
14.3 Cardiovascular Drug-Eluting Stents(DES) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. MIV Therapeutics Major Business
Table 5. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 6. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. MIV Therapeutics Recent Developments/Updates
Table 8. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 9. Orbusneich Major Business
Table 10. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 11. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Orbusneich Recent Developments/Updates
Table 13. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 14. Promed Medical Major Business
Table 15. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 16. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Promed Medical Recent Developments/Updates
Table 18. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 19. Relisys Medical Major Business
Table 20. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 21. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Relisys Medical Recent Developments/Updates
Table 23. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 24. Reva Medical Major Business
Table 25. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 26. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Reva Medical Recent Developments/Updates
Table 28. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 29. Sahajanand Major Business
Table 30. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 31. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sahajanand Recent Developments/Updates
Table 33. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 34. Sino Medical Major Business
Table 35. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 36. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sino Medical Recent Developments/Updates
Table 38. Sorin Basic Information, Manufacturing Base and Competitors
Table 39. Sorin Major Business
Table 40. Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 41. Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sorin Recent Developments/Updates
Table 43. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 44. Terumo Medical Major Business
Table 45. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 46. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Terumo Medical Recent Developments/Updates
Table 48. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 49. Abbott Vascular Major Business
Table 50. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 51. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Abbott Vascular Recent Developments/Updates
Table 53. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 54. Advantec Vascular Major Business
Table 55. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 56. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Advantec Vascular Recent Developments/Updates
Table 58. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 59. B.Braun Melsengen AG Major Business
Table 60. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 61. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. B.Braun Melsengen AG Recent Developments/Updates
Table 63. Biosensors Basic Information, Manufacturing Base and Competitors
Table 64. Biosensors Major Business
Table 65. Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 66. Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Biosensors Recent Developments/Updates
Table 68. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 69. Boston Scientific Major Business
Table 70. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 71. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Boston Scientific Recent Developments/Updates
Table 73. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 74. MicroPort Medical Major Business
Table 75. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 76. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. MicroPort Medical Recent Developments/Updates
Table 78. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Cardiovascular Drug-Eluting Stents(DES), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer
Table 83. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
Table 84. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
Table 85. Cardiovascular Drug-Eluting Stents(DES) New Market Entrants and Barriers to Market Entry
Table 86. Cardiovascular Drug-Eluting Stents(DES) Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Cardiovascular Drug-Eluting Stents(DES) Raw Material
Table 146. Key Manufacturers of Cardiovascular Drug-Eluting Stents(DES) Raw Materials
Table 147. Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
Table 148. Cardiovascular Drug-Eluting Stents(DES) Typical Customers
Table 1. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. MIV Therapeutics Major Business
Table 5. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 6. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. MIV Therapeutics Recent Developments/Updates
Table 8. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 9. Orbusneich Major Business
Table 10. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 11. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Orbusneich Recent Developments/Updates
Table 13. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 14. Promed Medical Major Business
Table 15. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 16. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Promed Medical Recent Developments/Updates
Table 18. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 19. Relisys Medical Major Business
Table 20. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 21. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Relisys Medical Recent Developments/Updates
Table 23. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 24. Reva Medical Major Business
Table 25. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 26. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Reva Medical Recent Developments/Updates
Table 28. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 29. Sahajanand Major Business
Table 30. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 31. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sahajanand Recent Developments/Updates
Table 33. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 34. Sino Medical Major Business
Table 35. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 36. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sino Medical Recent Developments/Updates
Table 38. Sorin Basic Information, Manufacturing Base and Competitors
Table 39. Sorin Major Business
Table 40. Sorin Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 41. Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sorin Recent Developments/Updates
Table 43. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 44. Terumo Medical Major Business
Table 45. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 46. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Terumo Medical Recent Developments/Updates
Table 48. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 49. Abbott Vascular Major Business
Table 50. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 51. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Abbott Vascular Recent Developments/Updates
Table 53. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 54. Advantec Vascular Major Business
Table 55. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 56. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Advantec Vascular Recent Developments/Updates
Table 58. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 59. B.Braun Melsengen AG Major Business
Table 60. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 61. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. B.Braun Melsengen AG Recent Developments/Updates
Table 63. Biosensors Basic Information, Manufacturing Base and Competitors
Table 64. Biosensors Major Business
Table 65. Biosensors Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 66. Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Biosensors Recent Developments/Updates
Table 68. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 69. Boston Scientific Major Business
Table 70. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 71. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Boston Scientific Recent Developments/Updates
Table 73. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 74. MicroPort Medical Major Business
Table 75. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product and Services
Table 76. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. MicroPort Medical Recent Developments/Updates
Table 78. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Cardiovascular Drug-Eluting Stents(DES), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer
Table 83. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Type Footprint
Table 84. Cardiovascular Drug-Eluting Stents(DES) Market: Company Product Application Footprint
Table 85. Cardiovascular Drug-Eluting Stents(DES) New Market Entrants and Barriers to Market Entry
Table 86. Cardiovascular Drug-Eluting Stents(DES) Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Cardiovascular Drug-Eluting Stents(DES) Raw Material
Table 146. Key Manufacturers of Cardiovascular Drug-Eluting Stents(DES) Raw Materials
Table 147. Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
Table 148. Cardiovascular Drug-Eluting Stents(DES) Typical Customers
LIST OF FIGURES
Figure 1. Cardiovascular Drug-Eluting Stents(DES) Picture
Figure 2. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Type in 2022
Figure 4. Passive Coating Examples
Figure 5. Active Coating Examples
Figure 6. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Cardiovascular Drug-Eluting Stents(DES) Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Cardiovascular Drug-Eluting Stents(DES) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Cardiovascular Drug-Eluting Stents(DES) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Cardiovascular Drug-Eluting Stents(DES) Market Drivers
Figure 73. Cardiovascular Drug-Eluting Stents(DES) Market Restraints
Figure 74. Cardiovascular Drug-Eluting Stents(DES) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Cardiovascular Drug-Eluting Stents(DES) in 2022
Figure 77. Manufacturing Process Analysis of Cardiovascular Drug-Eluting Stents(DES)
Figure 78. Cardiovascular Drug-Eluting Stents(DES) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Cardiovascular Drug-Eluting Stents(DES) Picture
Figure 2. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Type in 2022
Figure 4. Passive Coating Examples
Figure 5. Active Coating Examples
Figure 6. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Cardiovascular Drug-Eluting Stents(DES) Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Cardiovascular Drug-Eluting Stents(DES) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Cardiovascular Drug-Eluting Stents(DES) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Cardiovascular Drug-Eluting Stents(DES) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Cardiovascular Drug-Eluting Stents(DES) Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Cardiovascular Drug-Eluting Stents(DES) Market Drivers
Figure 73. Cardiovascular Drug-Eluting Stents(DES) Market Restraints
Figure 74. Cardiovascular Drug-Eluting Stents(DES) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Cardiovascular Drug-Eluting Stents(DES) in 2022
Figure 77. Manufacturing Process Analysis of Cardiovascular Drug-Eluting Stents(DES)
Figure 78. Cardiovascular Drug-Eluting Stents(DES) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
